MedPath
HSA Approval

POMAGEN CAPSULES 3MG

SIN16985P

POMAGEN CAPSULES 3MG

POMAGEN CAPSULES 3MG

April 12, 2024

LOTUS INTERNATIONAL PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantLOTUS INTERNATIONAL PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CAPSULE

ORAL

Medical Information

L04AX06

pomalidomide

Manufacturer Information

LOTUS INTERNATIONAL PTE. LTD.

Lotus Pharmaceutical Co., Ltd. Nantou Plant

Active Ingredients

Pomalidomide

3.0 mg

Pomalidomide

Documents

Patient Information Leaflets

POMAGEN CAPSULES PIL.docx

Approved: April 12, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.